Spruce Biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.
External link for Spruce Biosciences
611 Gateway Blvd
South San Francisco, California 94080, US
Happy Halloween and Diwali from Spruce Bio! We’re happy to gather in our San Francisco office today, where we celebrated with a friendly costume contest and catered lunch. Thank you to our team for bringing your enthusiasm and good spirits to the table! #Halloween #Diwali
Attending the Guggenheim Securities Healthcare Innovation Conference? Connect with our CEO, Javier Szwarcberg, and tune in to our webcast. More details about our participation here: https://lnkd.in/ezj76rjv
The ability to offer work flexibility is a core part of our culture. Ivona Zielinska, Senior Clinical Trial Manager, shares how Spruce empowers employees to balance their work and well-being so they can be their most productive and fulfilled selves. #LifeAtSpruce
We are committed to meaningfully changing the lives of patients with #endocrine disorders, such as classic Congenital Adrenal Hyperplasia (#CAH). Maralisa Vanandel (Mara), Senior Director, Patient Engagement & Advocacy, shares the importance of considering quality of life metrics in #clinical trials.
We prioritize the mental health of those we serve, including our very own team, providing a workplace that supports and uplifts employee wellness. We pride ourselves on our culture of wellness, which was recently ranked #7 by the San Francisco Business Times and Silicon Valley Business Journal as part of this year’s Best Places to Work in the Bay Area award. #WorldMentalHealthDay
Dr. Tânia Bachega: Champion for CAH Newborn Screening Meet Dr. Tania Bachega, a leading advocate for Congenital Adrenal Hyperplasia (#CAH) testing in Brazil. Through her efforts, CAH testing was successfully implemented in the Brazilian Newborn Screening Program, helping countless newborns and families receive an early diagnosis. Understanding the need for patient support within the CAH community, Dr. Bachega played a pivotal role as a scientific consultant in helping two of her patients establish the Brazilian Addisonian Association. This nonprofit now supports over 2,000 members, providing essential resources for patients and families affected by adrenal insufficiency across Brazil. In addition to her groundbreaking research, Dr. Bachega recently secured a parliamentary amendment to increase the production of hydrocortisone—a life-saving medication for CAH patients—at the Hospital das Clínicas. Her dedication to advancing CAH research and patient care has earned her a prestigious award from the I-CAH Registry, recognizing her contributions to improving global knowledge and clinical care. Most recently, she was awarded the highest honor from SLEP (Latin American Society of Pediatric Endocrinology), acknowledging the significant public health impact of her work in CAH.
It is a privilege to be working alongside the CARES Foundation, Inc. in advancing research and, ultimately, life-changing treatments for people living with Congenital Adrenal Hyperplasia (#CAH). Thank you for your ongoing support and education of the disorder for the CAH community.
Our September Update is now available! We encourage you to read up on all of the important events, research, community updates, and more in this month's update! Please visit https://lnkd.in/eUkSH4jC to view the full September 2024 Monthly Update. #CARES #CAH #CARESFoundation #CongenitalAdrenalHyperplasia #AnnualCAHEducationConference #CARESPFDD #CAHSupport #CAHAdvocacy
Dr. Richard Auchus: Serving Those Who Serve Dr. Richard Auchus is renowned as the world’s foremost authority on steroid-related conditions, making significant contributions to the advancement of care for Congenital Adrenal Hyperplasia (#CAH) and other adrenal disorders. Leading the first adult study offering a non-steroidal therapy option in Classic CAH. He has also co-authored Clinical Practice Guidelines revolutionizing patient care globally. Beyond his scientific achievements, Dr. Auchus has a distinguished service record as an Air Force officer and continues to serve as the Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. His unparalleled expertise attracts patients nationwide seeking his insights. Join us in honoring Dr. Auchus for his distinguished service to our nation and groundbreaking contributions to global patient care. #Changemaker #endocrinedisorders
Our CEO, Javier Szwarcberg, M.D., M.P.H., will present today at the H.C. Wainwright & Co., LLC 26th Annual Global Investment Conference. Details below and tune into the webcast: https://lnkd.in/eJdSrc3H
Today, we announced our participation in the upcoming H.C. Wainwright & Co., LLC 26th Annual Global Investment Conference in #NYC. Learn more and register for the webcast here: https://lnkd.in/gbHTi7pQ